I
TGTX icon

InceptionR’s TG Therapeutics TGTX Stock Holding History

InceptionR’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$471K Sell
8,572
-2,160
-20% -$88.4K 0.12% 327
2026
Q1 		$357K Buy
+10,732
New +$320K 0.09% 432
2025
Q3 		– Sell
-11,012
Closed -$396K – 934
2025
Q2 		$396K Buy
+11,012
New +$410K 0.09% 371
2025
Q1 		– Sell
-8,722
Closed -$263K – 830
2024
Q4 		$263K Buy
+8,722
New +$250K 0.06% 499

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

InceptionR's TGTX Position: Q2 2026 in Review

InceptionR reduced its TG Therapeutics (TGTX) stake by 20% in Q2 2026, selling an estimated $88.4K and leaving 8,572 shares worth $471K. The position accounts for 0.12% of the portfolio, ranked #327.

InceptionR first reported a position in TGTX in Q4 2024 and has held it in 4 quarters since. 427 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • InceptionR held 8,572 shares of TG Therapeutics worth $471K as of Q2 2026.
  • InceptionR sold 2,160 TG Therapeutics shares in Q2 2026, an estimated $88.4K.
  • TG Therapeutics made up 0.12% of InceptionR's portfolio in Q2 2026, its #327 holding.
  • InceptionR first reported a position in TG Therapeutics in Q4 2024 and has held it in 4 quarters since.
  • 427 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on InceptionR's 13F filing for Q2 2026, filed 11 Aug 2026.